Log In
BCIQ
Print this Print this
 

T121

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionNon-opioid, oral formulation of zoledronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat complex regional pain syndrome (CRPS)
Regulatory Designation U.S. - Orphan Drug (Treat complex regional pain syndrome (CRPS))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/16/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today